D
David C. Murray
Researcher at McGill University
Publications - 20
Citations - 6212
David C. Murray is an academic researcher from McGill University. The author has contributed to research in topics: Hemodialysis & End stage renal disease. The author has an hindex of 17, co-authored 20 publications receiving 6019 citations. Previous affiliations of David C. Murray include St. John's University & The Salvation Army.
Papers
More filters
Journal ArticleDOI
Clinical and echocardiographic disease in patients starting end-stage renal disease therapy
Robert N. Foley,Patrick S. Parfrey,Patrick S. Parfrey,John D. Harnett,John D. Harnett,Gloria M. Kent,Gloria M. Kent,Christopher J. Martin,Christopher J. Martin,David C. Murray,David C. Murray,Paul E. Barre,Paul E. Barre +12 more
TL;DR: It is concluded that clinical and echocardiographic cardiovascular disease are already present in a very high proportion of patients starting ESRD therapy and are independent mortality factors.
Journal ArticleDOI
The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease☆
Robert N. Foley,Patrick S. Parfrey,Patrick S. Parfrey,John D. Harnett,John D. Harnett,Gloria M. Kent,Gloria M. Kent,David C. Murray,David C. Murray,Paul E. Barre,Paul E. Barre +10 more
TL;DR: Anemia, an easily reversible feature of end- stage renal disease, is an independent risk factor for clinical and echocardiographic cardiac disease, as well as mortality in end-stage renal disease patients.
Journal ArticleDOI
Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors
John D. Harnett,Robert N. Foley,Gloria M. Kent,Paul E. Barre,David C. Murray,Patrick S. Parfrey +5 more
TL;DR: The prevalence of CHF on starting ESRD therapy and the subsequent annual incidence was high and independent and significant risk factors for CHF recurrence were ischemic heart disease and systolic dysfunction, anemia during dialysis therapy and hypoalbuminemia.
Journal ArticleDOI
Outcome and risk factors for left ventricular disorders in chronic uraemia
Patrick S. Parfrey,Robert N. Foley,John D. Harnett,Gloria M. Kent,David C. Murray,Paul E. Barre +5 more
TL;DR: Manifestations of left ventricular disease are frequent and persistent in chronic uraemia, and are associated with high risks of heart failure and death, and the degree of systolic dysfunction was associated with ischaemic heart disease and anaemia during follow-up.
Journal ArticleDOI
Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease.
Robert N. Foley,Patrick S. Parfrey,Patrick S. Parfrey,Patrick S. Parfrey,John D. Harnett,John D. Harnett,John D. Harnett,Gloria M. Kent,Gloria M. Kent,Gloria M. Kent,David C. Murray,David C. Murray,David C. Murray,Paul E. Barre,Paul E. Barre,Paul E. Barre +15 more
TL;DR: It is concluded that even moderate hypertension worsens the echocardiographic and clinical outcome in ESRD patients, especially in those without previous clinical cardiac disease.